Randomised controlled trial of a web-based cognitive behavioural intervention for psoriasis

ISRCTN ISRCTN01714240
DOI https://doi.org/10.1186/ISRCTN01714240
Secondary identifying numbers 7310
Submission date
21/05/2010
Registration date
21/05/2010
Last edited
29/07/2013
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Skin and Connective Tissue Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Chris Griffiths
Scientific

Stott Lane
Salford
M6 8HD
United Kingdom

Email chris.griffiths@srft.nhs.uk

Study information

Study designSingle centre randomised interventional treatment trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)GP practice
Study typeTreatment
Scientific title
Study acronymWeb based cognitive behaviour therapy for people with psoriasis
Study objectivesPsoriasis is a chronic inflammatory skin disease affecting approximately 2-3% of the population. The condition is incurable at this stage and the course is recurrent, with periods of remission. It is believed to be a genetic disease, with the genetic tendency thought to be triggered by various environmental factors including infection, skin trauma, certain medications and stress.

Previous research has shown that psoriasis patients have a high incidence of psychological distress, with studies reporting psychological disturbance in the order of 30 - 40% of patients. Psychological distress reported by psoriasis patients includes increased levels of anxiety, depression, excessive worry, reduced quality of life and impaired everyday functioning. Overall, psoriasis patients report more psychological distress than any other dermatology group.
Ethics approval(s)MREC approved (ref: 08/H1012/17)
Health condition(s) or problem(s) studiedTopic: Skin; Subtopic: Skin (all Subtopics); Disease: Dermatology
InterventionCognitive behaviour therapy (CBT) in a web-based format. This method allows participants to complete the study in privacy, at their own convenience and makes the treatment more broadly accessible.

Follow up length: 6 months
Intervention typeOther
Primary outcome measureSubjective reports of self efficacy
Secondary outcome measures1. Change in illness beliefs
2. Improved quality of life
3. Reduced alcohol consumption
Overall study start date01/04/2009
Completion date31/12/2009

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participantsPlanned sample size: 120
Key inclusion criteriaMale and female, lower age limit of 16 years
Key exclusion criteriaNot provided at time of registration
Date of first enrolment01/04/2009
Date of final enrolment31/12/2009

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Stott Lane
Salford
M6 8HD
United Kingdom

Sponsor information

Salford Royal NHS Foundation Trust (UK)
Hospital/treatment centre

Hope Hospital
Stott Lane
Salford
M6 8HD
England
United Kingdom

Website http://www.srht.nhs.uk
ROR logo "ROR" https://ror.org/019j78370

Funders

Funder type

Charity

Psoriasis and Psoriatic Arthritis Alliance (PAPAA) (UK)
Private sector organisation / Other non-profit organizations
Alternative name(s)
PAPAA
Location
United Kingdom

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/08/2013 Yes No